Several pathways have been discovered to be involved in SCD1-regulated tumor characteristics, such as the AMP-activated protein kinase (AMPK) pathway [15], the phosphatidylinositol-3 phosphate kinase (PI3K)/Akt/mTOR pathway [16], and the epidermal growth factor receptor (EGFR) pathway [17]. This evidence concerns the gene SCD and neoplasm.